{"component": "clause", "props": {"groups": [{"size": 16, "samples": [{"hash": "1B24xKrdOb9", "uri": "/contracts/1B24xKrdOb9#contingent-value-right", "label": "Merger Agreement (XOMA Royalty Corp)", "score": 36.7262153625, "published": true}, {"hash": "3yQBObzkH8J", "uri": "/contracts/3yQBObzkH8J#contingent-value-right", "label": "Agreement and Plan of Merger (XOMA Royalty Corp)", "score": 36.6194381714, "published": true}, {"hash": "4BQM9en9TvG", "uri": "/contracts/4BQM9en9TvG#contingent-value-right", "label": "Merger Agreement (HilleVax, Inc.)", "score": 36.5893211365, "published": true}], "snippet": "At or prior to the Offer Closing Time, Parent will authorize and duly adopt, execute and deliver, and will ensure that a duly qualified rights agent with respect to the CVRs mutually agreeable to Parent and the Company (a \u201cRights Agent\u201d) executes and delivers, a contingent value rights agreement in substantially the form attached as Exhibit C (the \u201cCVR Agreement\u201d), subject to any reasonable revisions to the CVR Agreement that are requested by such Rights Agent or the Representative thereunder (provided that such revisions are not, individually or in the aggregate, materially detrimental to any holder of CVRs). Parent and the Company shall cooperate, including by making changes to the form of CVR Agreement, as necessary to ensure that the CVRs are not subject to registration under the Securities Act, the Exchange Act or any applicable state securities or \u201cblue sky\u201d Laws.", "snippet_links": [{"key": "offer-closing-time", "type": "definition", "offset": [19, 37]}, {"key": "execute-and-deliver", "type": "clause", "offset": [77, 96]}, {"key": "duly-qualified", "type": "definition", "offset": [121, 135]}, {"key": "rights-agent", "type": "definition", "offset": [136, 148]}, {"key": "with-respect-to", "type": "clause", "offset": [149, 164]}, {"key": "to-parent", "type": "definition", "offset": [193, 202]}, {"key": "and-the-company", "type": "clause", "offset": [203, 218]}, {"key": "contingent-value-rights-agreement", "type": "definition", "offset": [263, 296]}, {"key": "exhibit-c", "type": "definition", "offset": [335, 344]}, {"key": "cvr-agreement", "type": "clause", "offset": [351, 364]}, {"key": "subject-to", "type": "clause", "offset": [368, 378]}, {"key": "requested-by", "type": "clause", "offset": [434, 446]}, {"key": "such-rights", "type": "definition", "offset": [447, 458]}, {"key": "the-representative", "type": "clause", "offset": [468, 486]}, {"key": "provided-that", "type": "definition", "offset": [499, 512]}, {"key": "in-the-aggregate", "type": "definition", "offset": [553, 569]}, {"key": "to-any-holder", "type": "definition", "offset": [594, 607]}, {"key": "the-company-shall", "type": "clause", "offset": [629, 646]}, {"key": "changes-to-the", "type": "definition", "offset": [678, 692]}, {"key": "form-of", "type": "clause", "offset": [693, 700]}, {"key": "to-ensure", "type": "clause", "offset": [729, 738]}, {"key": "registration-under-the-securities-act", "type": "clause", "offset": [772, 809]}, {"key": "the-exchange-act", "type": "definition", "offset": [811, 827]}, {"key": "state-securities", "type": "definition", "offset": [846, 862]}, {"key": "blue-sky", "type": "clause", "offset": [867, 875]}], "hash": "9ebba68b49570af3699684d22aa4e522", "id": 1}, {"size": 10, "samples": [{"hash": "1HqE0gVR1Cy", "uri": "/contracts/1HqE0gVR1Cy#contingent-value-right", "label": "Merger Agreement (Gazelle Parent, Inc.)", "score": 37.4763870239, "published": true}, {"hash": "1InMv4RwTEx", "uri": "/contracts/1InMv4RwTEx#contingent-value-right", "label": "Merger Agreement (Galera Therapeutics, Inc.)", "score": 37.2819976807, "published": true}], "snippet": "Prior to the Galera Effective Time but after the conversion of all Galera Series B Preferred Stock into Galera Common Stock, Galera shall declare a distribution (the \u201cPre-Closing Distribution\u201d) to holders of Galera Common Stock of record the right to receive one contingent value right (each, a \u201cCVR\u201d) for each outstanding share of Galera Common Stock held by such stockholder as of such date (less applicable withholding Taxes), each representing the right to receive contingent payments upon the occurrence of certain events set forth in, and subject to and in accordance with the terms and conditions of, the Contingent Value Rights Agreement in the form attached hereto as Exhibit G, to be entered into between Parent, Obsidian and Equiniti Trust Company, LLC (or such other nationally recognized rights agent agreed to between Galera and Obsidian) (the \u201cRights Agent\u201d), with such revisions thereto requested by the Rights Agent that are not, individually or in the aggregate, materially detrimental to the holders of CVRs and reasonably acceptable to \u2587\u2587\u2587\u2587\u2587\u2587 and Obsidian (the \u201cCVR Agreement\u201d). The record date for the Pre-Closing Distribution shall be the close of business on the last Business Day prior to the day on which the Galera Effective Time occurs and the payment date for the Pre-Closing Distribution shall be three (3) Business Days after the Galera Effective Time; provided that the payment of such distribution may be conditioned upon the occurrence of the Galera Effective Time. In connection with the Pre-Closing Distribution, Galera shall cause the CVR Agreement to be duly authorized, executed and delivered by \u2587\u2587\u2587\u2587\u2587\u2587 and the Exchange Agent.\n(a) The CVRs are solely contractual rights and shall not constitute equity or ownership interests in Parent, Galera, Obsidian or any of their respective Affiliates, and Parent, Galera and Obsidian shall cooperate, including by making changes to the CVR Agreement, as necessary to ensure that the CVRs are not subject to registration under the Securities Act, the Exchange Act or applicable state securities or \u201cblue sky\u201d Laws. Notwithstanding anything to the contrary herein or in the CVR Agreement, none of Parent, Galera, Obsidian or any of their respective Affiliates shall owe any fiduciary or other duties to any holder of CVRs, except to the extent expressly set forth in the CVR Agreement.\n(b) Galera agrees to pay all costs and fees of the Rights Agent contemplated by this Section 2.7 (the \u201cCVR Fees\u201d).", "snippet_links": [{"key": "prior-to-the", "type": "clause", "offset": [0, 12]}, {"key": "effective-time", "type": "clause", "offset": [20, 34]}, {"key": "conversion-of", "type": "clause", "offset": [49, 62]}, {"key": "series-b-preferred-stock", "type": "definition", "offset": [74, 98]}, {"key": "common-stock", "type": "clause", "offset": [111, 123]}, {"key": "a-distribution", "type": "clause", "offset": [146, 160]}, {"key": "closing-distribution", "type": "clause", "offset": [171, 191]}, {"key": "to-holders", "type": "clause", "offset": [194, 204]}, {"key": "of-record", "type": "definition", "offset": [228, 237]}, {"key": "right-to-receive", "type": "clause", "offset": [242, 258]}, {"key": "outstanding-share", "type": "definition", "offset": [311, 328]}, {"key": "applicable-withholding-taxes", "type": "definition", "offset": [399, 427]}, {"key": "contingent-payments", "type": "definition", "offset": [469, 488]}, {"key": "occurrence-of-certain-events", "type": "clause", "offset": [498, 526]}, {"key": "subject-to-and-in-accordance-with", "type": "clause", "offset": [545, 578]}, {"key": "terms-and-conditions-of", "type": "clause", "offset": [583, 606]}, {"key": "contingent-value-rights-agreement", "type": "definition", "offset": [612, 645]}, {"key": "exhibit-g", "type": "definition", "offset": [677, 686]}, {"key": "entered-into", "type": "clause", "offset": [694, 706]}, {"key": "trust-company", "type": "definition", "offset": [745, 758]}, {"key": "nationally-recognized", "type": "definition", "offset": [779, 800]}, {"key": "agreed-to", "type": "definition", "offset": [814, 823]}, {"key": "requested-by", "type": "clause", "offset": [903, 915]}, {"key": "the-rights-agent", "type": "clause", "offset": [916, 932]}, {"key": "in-the-aggregate", "type": "definition", "offset": [963, 979]}, {"key": "holders-of-cvrs", "type": "clause", "offset": [1011, 1026]}, {"key": "cvr-agreement", "type": "clause", "offset": [1082, 1095]}, {"key": "record-date", "type": "definition", "offset": [1103, 1114]}, {"key": "the-pre", "type": "clause", "offset": [1119, 1126]}, {"key": "close-of-business", "type": "definition", "offset": [1161, 1178]}, {"key": "the-day", "type": "definition", "offset": [1213, 1220]}, {"key": "payment-date", "type": "definition", "offset": [1271, 1283]}, {"key": "days-after", "type": "definition", "offset": [1345, 1355]}, {"key": "provided-that", "type": "definition", "offset": [1383, 1396]}, {"key": "payment-of", "type": "definition", "offset": [1401, 1411]}, {"key": "be-conditioned", "type": "clause", "offset": [1434, 1448]}, {"key": "in-connection-with", "type": "clause", "offset": [1499, 1517]}, {"key": "agreement-to-be", "type": "clause", "offset": [1575, 1590]}, {"key": "duly-authorized", "type": "clause", "offset": [1591, 1606]}, {"key": "executed-and-delivered", "type": "clause", "offset": [1608, 1630]}, {"key": "the-exchange-agent", "type": "clause", "offset": [1645, 1663]}, {"key": "contractual-rights", "type": "definition", "offset": [1689, 1707]}, {"key": "ownership-interests", "type": "definition", "offset": [1743, 1762]}, {"key": "respective-affiliates", "type": "definition", "offset": [1807, 1828]}, {"key": "changes-to-the", "type": "definition", "offset": [1899, 1913]}, {"key": "to-ensure", "type": "clause", "offset": [1942, 1951]}, {"key": "registration-under-the-securities-act", "type": "clause", "offset": [1985, 2022]}, {"key": "the-exchange-act", "type": "definition", "offset": [2024, 2040]}, {"key": "state-securities", "type": "definition", "offset": [2055, 2071]}, {"key": "blue-sky", "type": "clause", "offset": [2076, 2084]}, {"key": "notwithstanding-anything-to-the-contrary", "type": "clause", "offset": [2092, 2132]}, {"key": "other-duties", "type": "clause", "offset": [2263, 2275]}, {"key": "to-any-holder", "type": "definition", "offset": [2276, 2289]}, {"key": "except-to-the-extent", "type": "clause", "offset": [2299, 2319]}, {"key": "to-pay", "type": "clause", "offset": [2380, 2386]}, {"key": "costs-and-fees", "type": "definition", "offset": [2391, 2405]}], "hash": "834e02a79188e4b00d055192c63ef995", "id": 2}, {"size": 8, "samples": [{"hash": "6eqkkvmiJI", "uri": "/contracts/6eqkkvmiJI#contingent-value-right", "label": "Merger Agreement (Spyre Therapeutics, Inc.)", "score": 34.9712524414, "published": true}, {"hash": "jteZ5OMsEYC", "uri": "/contracts/jteZ5OMsEYC#contingent-value-right", "label": "Merger Agreement (Aeglea BioTherapeutics, Inc.)", "score": 34.8699531555, "published": true}, {"hash": "eyMa7UdsDEn", "uri": "/contracts/eyMa7UdsDEn#contingent-value-right", "label": "Merger Agreement (Aeglea BioTherapeutics, Inc.)", "score": 34.4729652405, "published": true}], "snippet": "(a) Holders of Parent Common Stock of record as of immediately prior to the First Effective Time shall be entitled to one contractual contingent value right (a \u201cCVR\u201d) issued by Parent subject to and in accordance with the terms and conditions of the CVR Agreement, attached hereto as Exhibit D (the \u201cCVR Agreement\u201d), for each share of Parent Common Stock held by such holders (less applicable withholding Taxes).\n(b) Within thirty (30) days of the First Effective Time, Parent shall authorize and duly adopt, execute and deliver, and will ensure that Exchange Agent executes and delivers, the CVR Agreement, subject to any reasonable revisions to the CVR Agreement that are requested by such Exchange Agent (provided that such revisions are not, individually or in the aggregate, detrimental or adverse, taken as a whole, to any holder of a CVR). Parent and the Company shall cooperate, including by making changes to the form of CVR Agreement, as necessary to ensure that the CVRs are not subject to registration under the Securities Act, the Exchange Act or any applicable state securities or \u201cblue sky\u201d laws.\n(c) Parent and the Exchange Agent shall, within thirty (30) days of the First Effective Time, duly authorize, execute and deliver the CVR Agreement.", "snippet_links": [{"key": "holders-of", "type": "clause", "offset": [4, 14]}, {"key": "parent-common-stock", "type": "definition", "offset": [15, 34]}, {"key": "of-record", "type": "definition", "offset": [35, 44]}, {"key": "prior-to-the", "type": "clause", "offset": [63, 75]}, {"key": "first-effective-time", "type": "clause", "offset": [76, 96]}, {"key": "by-parent", "type": "clause", "offset": [174, 183]}, {"key": "subject-to-and-in-accordance-with", "type": "clause", "offset": [184, 217]}, {"key": "terms-and-conditions-of-the", "type": "clause", "offset": [222, 249]}, {"key": "cvr-agreement", "type": "clause", "offset": [250, 263]}, {"key": "exhibit-d", "type": "clause", "offset": [284, 293]}, {"key": "applicable-withholding-taxes", "type": "definition", "offset": [382, 410]}, {"key": "within-thirty", "type": "clause", "offset": [417, 430]}, {"key": "execute-and-deliver", "type": "clause", "offset": [509, 528]}, {"key": "requested-by", "type": "clause", "offset": [674, 686]}, {"key": "provided-that", "type": "definition", "offset": [708, 721]}, {"key": "in-the-aggregate", "type": "definition", "offset": [762, 778]}, {"key": "taken-as-a-whole", "type": "clause", "offset": [804, 820]}, {"key": "to-any-holder", "type": "definition", "offset": [822, 835]}, {"key": "the-company-shall", "type": "clause", "offset": [858, 875]}, {"key": "changes-to-the", "type": "definition", "offset": [907, 921]}, {"key": "form-of", "type": "clause", "offset": [922, 929]}, {"key": "to-ensure", "type": "clause", "offset": [958, 967]}, {"key": "registration-under-the-securities-act", "type": "clause", "offset": [1001, 1038]}, {"key": "the-exchange-act", "type": "definition", "offset": [1040, 1056]}, {"key": "state-securities", "type": "definition", "offset": [1075, 1091]}, {"key": "blue-sky", "type": "clause", "offset": [1096, 1104]}, {"key": "agent-shall", "type": "definition", "offset": [1140, 1151]}], "hash": "2456deaa1fdb41da1b23a526761113c8", "id": 3}, {"size": 3, "samples": [{"hash": "4vKrF4gdNbP", "uri": "/contracts/4vKrF4gdNbP#contingent-value-right", "label": "Merger Agreement (Homology Medicines, Inc.)", "score": 34.9603004456, "published": true}, {"hash": "2Pklevxxnu6", "uri": "/contracts/2Pklevxxnu6#contingent-value-right", "label": "Merger Agreement (Homology Medicines, Inc.)", "score": 34.8726882935, "published": true}], "snippet": "(a) Prior to the Effective Time, Homology shall declare a distribution (the \u201cPre-Closing Distribution\u201d) to holders of Homology Common Stock of record the right to receive one contingent value right (each, a \u201cCVR\u201d) for each outstanding share of Homology Common Stock held by such stockholder as of such date, each representing the right to receive contingent payments upon the occurrence of certain events set forth in, and subject to and in accordance with the terms and conditions of, the Contingent Value Rights Agreement in the form attached hereto as Exhibit E, to be entered into between Homology and Equiniti Trust Company, LLC (or such other nationally recognized rights agent agreed to between Homology and Q32) (the \u201cRights Agent\u201d), with such revisions thereto requested by the Rights Agent that are not, individually or in the aggregate, materially detrimental to the holders of CVRs and reasonably acceptable to Homology and Q32 (the \u201cCVR Agreement\u201d). The record date for the Pre-Closing Distribution shall be the close of business on the last Business Day prior to the day on which the Effective Time occurs and the payment date for the Pre-Closing Distribution shall be three (3) Business Days after the Effective Time; provided that the payment of such distribution may be conditioned upon the occurrence of the Effective Time. In connection with the Pre-Closing Distribution, Homology shall cause the CVR Agreement to be duly authorized, executed and delivered by Homology and the Exchange Agent.\n(b) Homology agrees to pay all reasonable costs and fees associated with any action contemplated by this Section 2.5 (the \u201cCVR Fees\u201d).", "snippet_links": [{"key": "prior-to-the-effective-time", "type": "clause", "offset": [4, 31]}, {"key": "a-distribution", "type": "clause", "offset": [56, 70]}, {"key": "closing-distribution", "type": "clause", "offset": [81, 101]}, {"key": "to-holders", "type": "clause", "offset": [104, 114]}, {"key": "common-stock", "type": "clause", "offset": [127, 139]}, {"key": "of-record", "type": "definition", "offset": [140, 149]}, {"key": "right-to-receive", "type": "clause", "offset": [154, 170]}, {"key": "outstanding-share", "type": "definition", "offset": [223, 240]}, {"key": "contingent-payments", "type": "definition", "offset": [347, 366]}, {"key": "occurrence-of-certain-events", "type": "clause", "offset": [376, 404]}, {"key": "subject-to-and-in-accordance-with", "type": "clause", "offset": [423, 456]}, {"key": "terms-and-conditions-of", "type": "clause", "offset": [461, 484]}, {"key": "contingent-value-rights-agreement", "type": "definition", "offset": [490, 523]}, {"key": "exhibit-e", "type": "definition", "offset": [555, 564]}, {"key": "entered-into", "type": "clause", "offset": [572, 584]}, {"key": "trust-company", "type": "definition", "offset": [615, 628]}, {"key": "nationally-recognized", "type": "definition", "offset": [649, 670]}, {"key": "agreed-to", "type": "definition", "offset": [684, 693]}, {"key": "requested-by", "type": "clause", "offset": [770, 782]}, {"key": "the-rights-agent", "type": "clause", "offset": [783, 799]}, {"key": "in-the-aggregate", "type": "definition", "offset": [830, 846]}, {"key": "holders-of-cvrs", "type": "clause", "offset": [878, 893]}, {"key": "cvr-agreement", "type": "clause", "offset": [946, 959]}, {"key": "record-date", "type": "definition", "offset": [967, 978]}, {"key": "the-pre", "type": "clause", "offset": [983, 990]}, {"key": "close-of-business", "type": "definition", "offset": [1025, 1042]}, {"key": "the-day", "type": "definition", "offset": [1077, 1084]}, {"key": "payment-date", "type": "definition", "offset": [1128, 1140]}, {"key": "after-the-effective-time", "type": "clause", "offset": [1207, 1231]}, {"key": "provided-that", "type": "definition", "offset": [1233, 1246]}, {"key": "payment-of", "type": "definition", "offset": [1251, 1261]}, {"key": "be-conditioned", "type": "clause", "offset": [1284, 1298]}, {"key": "in-connection-with", "type": "clause", "offset": [1342, 1360]}, {"key": "agreement-to-be", "type": "clause", "offset": [1420, 1435]}, {"key": "duly-authorized", "type": "clause", "offset": [1436, 1451]}, {"key": "executed-and-delivered", "type": "clause", "offset": [1453, 1475]}, {"key": "the-exchange-agent", "type": "clause", "offset": [1492, 1510]}, {"key": "to-pay", "type": "clause", "offset": [1532, 1538]}, {"key": "costs-and-fees", "type": "definition", "offset": [1554, 1568]}, {"key": "associated-with", "type": "definition", "offset": [1569, 1584]}, {"key": "any-action", "type": "definition", "offset": [1585, 1595]}], "hash": "3be5849648c22324b061fc8ea1b1278b", "id": 4}, {"size": 3, "samples": [{"hash": "6TRs8II3ChE", "uri": "/contracts/6TRs8II3ChE#contingent-value-right", "label": "Agreement and Plan of Merger and Reorganization (Cyclerion Therapeutics, Inc.)", "score": 37.2464065552, "published": true}], "snippet": "(a) Prior to the First Effective Time, Parent shall declare a distribution (the \u201cClosing Distribution\u201d) to holders of Parent Common Stock and Parent Preferred Stock of record as of immediately prior to the First Effective Time (including, for the avoidance of doubt, those shares of Parent Common Stock with respect to Parent Restricted Stock Awards accelerated pursuant to Section 6.6(e)) of the right to receive one contingent value right (each, a \u201cCVR\u201d) for each outstanding share of Parent Common Stock or Parent Preferred Stock held by such stockholder as of such date (less applicable withholding taxes), each representing the right to receive contingent payments upon the occurrence of certain events set forth in, and subject to and in accordance with the terms and conditions of, the Contingent Value Rights Agreement in the form attached hereto as Exhibit F (the \u201cCVR Agreement\u201d). The record date for the Closing Distribution shall be the close of business on the Business Day prior to the date on which the First Effective Time occurs and the payment date for which shall be three (3) Business Days after the First Effective Time; provided that the payment of such distribution may be conditioned upon the occurrence of the First Effective Time.\n(b) Parent and the Exchange Agent shall, at or prior to the First Effective Time, duly authorize, execute and deliver the CVR Agreement, subject to any reasonable revisions to the CVR Agreement that are requested by such Exchange Agent and are reasonably acceptable to the Company and Parent.\n(c) Parent shall pay all costs and fees associated with any action contemplated by this Section 2.9 (the \u201cCVR Fees\u201d).", "snippet_links": [{"key": "prior-to-the", "type": "clause", "offset": [4, 16]}, {"key": "first-effective-time", "type": "clause", "offset": [17, 37]}, {"key": "a-distribution", "type": "clause", "offset": [60, 74]}, {"key": "closing-distribution", "type": "clause", "offset": [81, 101]}, {"key": "holders-of", "type": "clause", "offset": [107, 117]}, {"key": "parent-common-stock-and-parent-preferred-stock", "type": "clause", "offset": [118, 164]}, {"key": "of-record", "type": "definition", "offset": [165, 174]}, {"key": "for-the-avoidance-of-doubt", "type": "clause", "offset": [239, 265]}, {"key": "shares-of-parent-common-stock", "type": "clause", "offset": [273, 302]}, {"key": "parent-restricted-stock-awards", "type": "clause", "offset": [319, 349]}, {"key": "pursuant-to-section", "type": "clause", "offset": [362, 381]}, {"key": "right-to-receive", "type": "clause", "offset": [397, 413]}, {"key": "outstanding-share", "type": "definition", "offset": [466, 483]}, {"key": "applicable-withholding-taxes", "type": "definition", "offset": [580, 608]}, {"key": "contingent-payments", "type": "definition", "offset": [650, 669]}, {"key": "occurrence-of-certain-events", "type": "clause", "offset": [679, 707]}, {"key": "subject-to-and-in-accordance-with", "type": "clause", "offset": [726, 759]}, {"key": "terms-and-conditions-of", "type": "clause", "offset": [764, 787]}, {"key": "contingent-value-rights-agreement", "type": "definition", "offset": [793, 826]}, {"key": "exhibit-f", "type": "clause", "offset": [858, 867]}, {"key": "cvr-agreement", "type": "clause", "offset": [874, 887]}, {"key": "record-date", "type": "definition", "offset": [895, 906]}, {"key": "the-closing", "type": "definition", "offset": [911, 922]}, {"key": "close-of-business", "type": "definition", "offset": [949, 966]}, {"key": "the-business", "type": "clause", "offset": [970, 982]}, {"key": "payment-date", "type": "definition", "offset": [1054, 1066]}, {"key": "days-after", "type": "definition", "offset": [1105, 1115]}, {"key": "provided-that", "type": "definition", "offset": [1142, 1155]}, {"key": "payment-of", "type": "definition", "offset": [1160, 1170]}, {"key": "be-conditioned", "type": "clause", "offset": [1193, 1207]}, {"key": "agent-shall", "type": "definition", "offset": [1285, 1296]}, {"key": "execute-and-deliver", "type": "clause", "offset": [1355, 1374]}, {"key": "requested-by", "type": "clause", "offset": [1460, 1472]}, {"key": "to-the-company", "type": "definition", "offset": [1523, 1537]}, {"key": "costs-and-fees", "type": "definition", "offset": [1575, 1589]}, {"key": "associated-with", "type": "definition", "offset": [1590, 1605]}, {"key": "any-action", "type": "definition", "offset": [1606, 1616]}], "hash": "c33a63851d5dfe0214aa67fd2bb0c82d", "id": 5}, {"size": 2, "samples": [{"hash": "cogx5nGujs4", "uri": "/contracts/cogx5nGujs4#contingent-value-right", "label": "Merger Agreement (Carisma Therapeutics Inc.)", "score": 36.4743309021, "published": true}, {"hash": "6siA2zLYebt", "uri": "/contracts/6siA2zLYebt#contingent-value-right", "label": "Merger Agreement (Ocugen, Inc.)", "score": 36.4743309021, "published": true}], "snippet": "Prior to the Effective Time, Parent shall declare a distribution (the \u201cPre-Closing Distribution\u201d) to holders of Parent Common Stock of record the right to receive one contingent value right (each, a \u201cCVR\u201d) for each outstanding share of Parent Common Stock held by such stockholder as of such date, each representing the right to receive contingent payments upon the occurrence of certain events set forth in, and subject to and in accordance with the terms and conditions of, the Contingent Value Rights Agreement in the form attached hereto as Exhibit D, to be entered into between Parent and Computershare (or such other nationally recognized rights agent agreed to between Parent and the Company) (the \u201cRights Agent\u201d), with such revisions thereto requested by the Rights Agent that are not, individually or in the aggregate, materially detrimental to the holders of CVRs and reasonably acceptable to Parent and the Company (the \u201cCVR Agreement\u201d). The record date for the Pre-Closing Distribution shall be the close of business on the last Business Day prior to the day on which the Effective Time occurs.", "snippet_links": [{"key": "prior-to-the-effective-time", "type": "clause", "offset": [0, 27]}, {"key": "a-distribution", "type": "clause", "offset": [50, 64]}, {"key": "closing-distribution", "type": "clause", "offset": [75, 95]}, {"key": "to-holders", "type": "clause", "offset": [98, 108]}, {"key": "parent-common-stock", "type": "definition", "offset": [112, 131]}, {"key": "of-record", "type": "definition", "offset": [132, 141]}, {"key": "right-to-receive", "type": "clause", "offset": [146, 162]}, {"key": "outstanding-share", "type": "definition", "offset": [215, 232]}, {"key": "contingent-payments", "type": "definition", "offset": [337, 356]}, {"key": "occurrence-of-certain-events", "type": "clause", "offset": [366, 394]}, {"key": "subject-to-and-in-accordance-with", "type": "clause", "offset": [413, 446]}, {"key": "terms-and-conditions-of", "type": "clause", "offset": [451, 474]}, {"key": "contingent-value-rights-agreement", "type": "definition", "offset": [480, 513]}, {"key": "exhibit-d", "type": "clause", "offset": [545, 554]}, {"key": "entered-into", "type": "clause", "offset": [562, 574]}, {"key": "nationally-recognized", "type": "definition", "offset": [623, 644]}, {"key": "agreed-to", "type": "definition", "offset": [658, 667]}, {"key": "and-the-company", "type": "clause", "offset": [683, 698]}, {"key": "requested-by", "type": "clause", "offset": [750, 762]}, {"key": "the-rights-agent", "type": "clause", "offset": [763, 779]}, {"key": "in-the-aggregate", "type": "definition", "offset": [810, 826]}, {"key": "holders-of-cvrs", "type": "clause", "offset": [858, 873]}, {"key": "to-parent", "type": "definition", "offset": [900, 909]}, {"key": "cvr-agreement", "type": "clause", "offset": [932, 945]}, {"key": "record-date", "type": "definition", "offset": [953, 964]}, {"key": "the-pre", "type": "clause", "offset": [969, 976]}, {"key": "close-of-business", "type": "definition", "offset": [1011, 1028]}, {"key": "business-day", "type": "definition", "offset": [1041, 1053]}, {"key": "the-day", "type": "definition", "offset": [1063, 1070]}], "hash": "6c81e69149029072dfa003cfa7154a46", "id": 6}, {"size": 2, "samples": [{"hash": "jWlfRgqNoQ7", "uri": "/contracts/jWlfRgqNoQ7#contingent-value-right", "label": "Business Combination Agreement (ESSA Pharma Inc.)", "score": 36.5318260193, "published": true}], "snippet": "At or prior to the Effective Time, Parent and the Purchaser will authorize and duly adopt, execute and deliver, and will ensure that the Rights Agent executes and delivers the CVR Agreement, subject to any reasonable revisions to the CVR Agreement that are requested by such Rights Agent or the Representative thereunder (provided that such revisions are not, individually or in the aggregate, materially detrimental to any holder of CVRs). Parent, Purchaser and the Company shall cooperate, including by making changes to the form of CVR Agreement, as necessary to ensure that the CVRs are not subject to registration under the Securities Laws or any applicable state securities or \u201cblue sky\u201d Laws.", "snippet_links": [{"key": "prior-to-the-effective-time", "type": "clause", "offset": [6, 33]}, {"key": "the-purchaser-will", "type": "clause", "offset": [46, 64]}, {"key": "execute-and-deliver", "type": "clause", "offset": [91, 110]}, {"key": "the-rights-agent", "type": "clause", "offset": [133, 149]}, {"key": "cvr-agreement", "type": "clause", "offset": [176, 189]}, {"key": "subject-to", "type": "clause", "offset": [191, 201]}, {"key": "requested-by", "type": "clause", "offset": [257, 269]}, {"key": "such-rights", "type": "definition", "offset": [270, 281]}, {"key": "the-representative", "type": "clause", "offset": [291, 309]}, {"key": "provided-that", "type": "definition", "offset": [322, 335]}, {"key": "in-the-aggregate", "type": "definition", "offset": [376, 392]}, {"key": "to-any-holder", "type": "definition", "offset": [417, 430]}, {"key": "the-company-shall", "type": "clause", "offset": [463, 480]}, {"key": "changes-to-the", "type": "definition", "offset": [512, 526]}, {"key": "form-of", "type": "clause", "offset": [527, 534]}, {"key": "to-ensure", "type": "clause", "offset": [563, 572]}, {"key": "registration-under-the-securities-laws", "type": "clause", "offset": [606, 644]}, {"key": "state-securities", "type": "definition", "offset": [663, 679]}, {"key": "blue-sky", "type": "clause", "offset": [684, 692]}], "hash": "e0f996b74ff5dd2fb057beadcf0fff04", "id": 7}, {"size": 2, "samples": [{"hash": "4vPukfktuPQ", "uri": "/contracts/4vPukfktuPQ#contingent-value-right", "label": "Merger Agreement (Kezar Life Sciences, Inc.)", "score": 37.2409324646, "published": true}], "snippet": "At or prior to the Offer Closing Time, the Buyer Entities will authorize and duly adopt, execute and deliver, and will ensure that a duly qualified rights agent with respect to the CVRs mutually agreeable to the Buyer Entities and the Company (a \u201cRights Agent\u201d) executes and delivers, a contingent value rights agreement in substantially the form attached as Exhibit C (the \u201cCVR Agreement\u201d), subject to any reasonable revisions to the CVR Agreement that are requested by such Rights Agent or the Representative thereunder (provided that such revisions are not, individually or in the aggregate, materially detrimental to any holder of CVRs). The Buyer Entities and the Company shall cooperate, including by making changes to the form of CVR Agreement, as necessary to ensure that the CVRs are not subject to registration under the Securities Act, the Exchange Act or any applicable state securities or \u201cblue sky\u201d Laws.", "snippet_links": [{"key": "offer-closing-time", "type": "definition", "offset": [19, 37]}, {"key": "buyer-entities", "type": "definition", "offset": [43, 57]}, {"key": "execute-and-deliver", "type": "clause", "offset": [89, 108]}, {"key": "duly-qualified", "type": "definition", "offset": [133, 147]}, {"key": "rights-agent", "type": "definition", "offset": [148, 160]}, {"key": "with-respect-to", "type": "clause", "offset": [161, 176]}, {"key": "to-the-buyer", "type": "clause", "offset": [205, 217]}, {"key": "and-the-company", "type": "clause", "offset": [227, 242]}, {"key": "contingent-value-rights-agreement", "type": "definition", "offset": [287, 320]}, {"key": "exhibit-c", "type": "definition", "offset": [359, 368]}, {"key": "cvr-agreement", "type": "clause", "offset": [375, 388]}, {"key": "subject-to", "type": "clause", "offset": [392, 402]}, {"key": "requested-by", "type": "clause", "offset": [458, 470]}, {"key": "such-rights", "type": "definition", "offset": [471, 482]}, {"key": "the-representative", "type": "clause", "offset": [492, 510]}, {"key": "provided-that", "type": "definition", "offset": [523, 536]}, {"key": "in-the-aggregate", "type": "definition", "offset": [577, 593]}, {"key": "to-any-holder", "type": "definition", "offset": [618, 631]}, {"key": "the-company-shall", "type": "clause", "offset": [665, 682]}, {"key": "changes-to-the", "type": "definition", "offset": [714, 728]}, {"key": "form-of", "type": "clause", "offset": [729, 736]}, {"key": "to-ensure", "type": "clause", "offset": [765, 774]}, {"key": "registration-under-the-securities-act", "type": "clause", "offset": [808, 845]}, {"key": "the-exchange-act", "type": "definition", "offset": [847, 863]}, {"key": "state-securities", "type": "definition", "offset": [882, 898]}, {"key": "blue-sky", "type": "clause", "offset": [903, 911]}], "hash": "2836eec1a3df59bdbf5824702711d05e", "id": 8}, {"size": 2, "samples": [{"hash": "hwDDdFAlaQZ", "uri": "/contracts/hwDDdFAlaQZ#contingent-value-right", "label": "Agreement and Plan of Merger (Rallybio Corp)", "score": 37.1642723083, "published": true}], "snippet": "Prior to the Effective Time, Parent shall declare a distribution (the \u201cPre-Closing Distribution\u201d) to holders of (a) Parent Common Stock, (b) Pre-Funded Warrants (c) Parent restricted stock units and (d) In the Money Parent Options of one contingent value right (each, a \u201cCVR\u201d) for each outstanding (i) share of Parent Common Stock, (ii) Pre-Funded Warrant, (iii) Parent restricted stock units and (iv) In the Money Parent Option held by such holder as of the close of business on the record date described below, each representing the right to receive contingent payments upon the occurrence of certain events set forth in, and subject to and in accordance with the terms and conditions of, the Contingent Value Rights Agreement in the form attached hereto as Exhibit D, to be entered into between Parent and Computershare Trust Company, N.A. (the \u201cRights Agent\u201d), with such revisions thereto requested by the Rights Agent that are not, individually or in the aggregate, materially detrimental to the holders of CVRs and reasonably acceptable to the Company and Parent (the \u201cCVR Agreement\u201d). The record date for the Pre-Closing Distribution shall be the last Business Day prior to the day on which the Effective Time occurs; provided that the Pre-Closing Distribution may be conditioned upon the occurrence of the Effective Time. In connection with the Pre-Closing Distribution, Parent shall cause the CVR Agreement to be duly authorized, executed and delivered by \u2587\u2587\u2587\u2587\u2587\u2587 and the Rights Agent.", "snippet_links": [{"key": "prior-to-the-effective-time", "type": "clause", "offset": [0, 27]}, {"key": "a-distribution", "type": "clause", "offset": [50, 64]}, {"key": "closing-distribution", "type": "clause", "offset": [75, 95]}, {"key": "to-holders", "type": "clause", "offset": [98, 108]}, {"key": "parent-common-stock", "type": "definition", "offset": [116, 135]}, {"key": "funded-warrants", "type": "clause", "offset": [145, 160]}, {"key": "parent-restricted-stock-units", "type": "definition", "offset": [165, 194]}, {"key": "parent-options", "type": "definition", "offset": [216, 230]}, {"key": "in-the-money-parent-option", "type": "definition", "offset": [402, 428]}, {"key": "close-of-business", "type": "definition", "offset": [459, 476]}, {"key": "record-date", "type": "definition", "offset": [484, 495]}, {"key": "right-to-receive", "type": "clause", "offset": [535, 551]}, {"key": "contingent-payments", "type": "definition", "offset": [552, 571]}, {"key": "occurrence-of-certain-events", "type": "clause", "offset": [581, 609]}, {"key": "subject-to-and-in-accordance-with", "type": "clause", "offset": [628, 661]}, {"key": "terms-and-conditions-of", "type": "clause", "offset": [666, 689]}, {"key": "contingent-value-rights-agreement", "type": "definition", "offset": [695, 728]}, {"key": "exhibit-d", "type": "clause", "offset": [760, 769]}, {"key": "entered-into", "type": "clause", "offset": [777, 789]}, {"key": "computershare-trust-company", "type": "definition", "offset": [809, 836]}, {"key": "requested-by", "type": "clause", "offset": [893, 905]}, {"key": "the-rights-agent", "type": "clause", "offset": [906, 922]}, {"key": "in-the-aggregate", "type": "definition", "offset": [953, 969]}, {"key": "holders-of-cvrs", "type": "clause", "offset": [1001, 1016]}, {"key": "to-the-company", "type": "definition", "offset": [1043, 1057]}, {"key": "cvr-agreement", "type": "clause", "offset": [1075, 1088]}, {"key": "the-pre", "type": "clause", "offset": [1112, 1119]}, {"key": "business-day", "type": "definition", "offset": [1159, 1171]}, {"key": "the-day", "type": "definition", "offset": [1181, 1188]}, {"key": "provided-that", "type": "definition", "offset": [1225, 1238]}, {"key": "be-conditioned", "type": "clause", "offset": [1272, 1286]}, {"key": "in-connection-with", "type": "clause", "offset": [1330, 1348]}, {"key": "agreement-to-be", "type": "clause", "offset": [1406, 1421]}, {"key": "duly-authorized", "type": "clause", "offset": [1422, 1437]}, {"key": "executed-and-delivered", "type": "clause", "offset": [1439, 1461]}], "hash": "fa5014901ea2c461ba64372d20cc3011", "id": 9}, {"size": 1, "samples": [{"hash": "50nbCdmJWiO", "uri": "/contracts/50nbCdmJWiO#contingent-value-right", "label": "Limited Partnership Agreement (3100 Glendale Joint Venture)", "score": 18.0, "published": true}], "snippet": "Upon issuance of a Class C OP Unit, the holder thereof shall also receive one Contingent Value Right which right shall attach to and remain inseparable,", "snippet_links": [{"key": "class-c-op-unit", "type": "definition", "offset": [19, 34]}, {"key": "the-holder", "type": "clause", "offset": [36, 46]}], "hash": "04affc5c52143608d6190b8d6224acd4", "id": 10}], "next_curs": "Cl8SWWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjsLEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2Ih9jb250aW5nZW50LXZhbHVlLXJpZ2h0IzAwMDAwMDBhDKIBAmVuGAAgAA==", "clause": {"children": [["no-additional-payments", "No Additional Payments"], ["transferability", "Transferability"], ["expiration-date", "Expiration Date"], ["determination-of-payments", "Determination of Payments"], ["payment-entitlement", "Payment Entitlement"]], "size": 67, "parents": [["description-of-transaction", "Description of Transaction"], ["the-merger", "The Merger"], ["whereas", "WHEREAS"], ["certain-governance-matters", "Certain Governance Matters"], ["the-arrangement", "The Arrangement"]], "title": "Contingent Value Right", "id": "contingent-value-right", "related": [["contingent-value-rights", "Contingent Value Rights", "<strong>Contingent Value Rights</strong>"], ["contingent-payment", "Contingent Payment", "Contingent Payment"], ["contingent-consideration", "Contingent Consideration", "Contingent Consideration"], ["contingent-payments", "Contingent Payments", "Contingent Payments"], ["contingent-funding", "CONTINGENT FUNDING", "CONTINGENT FUNDING"]], "related_snippets": [], "updated": "2026-07-16T05:40:14+00:00", "also_ask": [], "drafting_tip": "Define triggering events precisely to avoid ambiguity; specify calculation methods for payments to ensure enforceability; set clear timelines for obligations to facilitate compliance.", "explanation": "A Contingent Value Right (CVR) is a contractual provision that grants holders the right to receive additional benefits if certain future events or performance targets are met. Typically used in mergers and acquisitions, CVRs may entitle shareholders to extra payments if a company achieves specific milestones, such as regulatory approvals or revenue thresholds, after the deal closes. This clause is designed to bridge valuation gaps and align interests by ensuring that stakeholders are compensated if anticipated value materializes post-transaction."}, "json": true, "cursor": ""}}